Both in Pharmaceuticals
Upstream Bio vs ALX Oncology Holdings
Over the past year UPB returned −86.4% and ALXO returned −22.3%; their daily moves had a correlation of 0.27.
UPB −86.4% ALXO −22.3%Growth of $1, one year, split-adjusted
| Metric | UPB | ALXO |
|---|---|---|
| Price | $3.41 | $1.22 |
| Market cap | $186.8M | $168.7M |
| Today | +4.28% | 0.00% |
| 1 month | −32.3% | −6.2% |
| 6 months | −63.7% | −27.8% |
| Year to date | −87.4% | +8.0% |
| 1 year | −85.9% | −23.3% |
| Revenue growth (YoY) | −17.5% | — |
| Gross margin | 100.0% | — |
| Net margin | −5136.1% | — |
| P/E (TTM) | — | — |
| Price / sales | 59.1× | — |
| Net cash | $261.3M | $128.5M |
| Dividend yield | — | — |
| Volatility (60d) | 83.4% | 88.9% |
| Short % of float | 13.2% | 6.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).